Durability of the response to peginterferon-alfa2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.
Autori:
Giordanino C, Sacco M, Ceretto S, Smedile A, Ciancio A, Cariti G, De Blasi T, Picciotto A, Marenco S, Grasso A, Pirisi M, Smirne C, Colletta C, Traverso A, Mazzucco D, Ciccone G, Simondi D, Rizzetto M, Saracco G.
Rivista:
Eur J Gastroenterol Hepatol 2014; 26: 52-8. doi: 10.1097/MEG.0b013e328362dc99. (IF 2.152)